Summary

In the Middle East and Africa are investing significantly in expanding and modernizing their healthcare infrastructure. The development of new hospitals, clinics, and medical facilities creates opportunities for the adoption of therapeutic devices across various healthcare settings. The Middle East & Africa region is experiencing a rising burden of chronic diseases, including cardiovascular diseases, diabetes, and respiratory disorders. Therapeutic devices play a crucial role in the management and treatment of these conditions, driving the demand for such devices in the market. Several countries in the Middle East & Africa region are increasing their healthcare expenditure to enhance the quality of healthcare services. This includes investments in medical technologies and therapeutic devices to meet the growing healthcare needs of the population. There is a growing awareness among the population in the Middle East & Africa region about the importance of healthcare and the availability of advanced medical treatments. This increased awareness contributes to a higher demand for therapeutic devices. Some countries in the Middle East & Africa region, such as the United Arab Emirates, have become hubs for medical tourism. The availability of advanced therapeutic devices and high-quality healthcare services attracts patients from other regions, contributing to the growth of the market. Collaboration between the public and private sectors in healthcare is becoming increasingly common in the Middle East & Africa region. Public-private partnerships can lead to improved healthcare infrastructure and the incorporation of advanced therapeutic devices in both public and private healthcare facilities. The Middle East & Africa region has a youthful and growing population. As the population increases, there is a corresponding rise in healthcare needs, including the demand for therapeutic devices for various medical conditions. The most in-demand therapeutic devices in the Middle East & Africa region are cardiovascular devices, followed by orthopedic devices and diagnostic imaging devices. This is due to the high prevalence of cardiovascular diseases, musculoskeletal disorders, and cancer in the region. Governments and healthcare organizations in the Middle East & Africa region are increasingly emphasizing preventive healthcare measures. Therapeutic devices that support early detection and prevention of diseases are in demand, aligning with the regional focus on public health.

According to the research report, “Middle East & Africa Therapeutic Device Market Outlook, 2028” published by Bonafide Research, the market is anticipated to cross around USD 8 Billion market size by 2028. The adoption of telehealth solutions and remote patient monitoring has been on the rise in the MEA region. This trend includes the use of therapeutic devices that enable remote monitoring and treatment, allowing healthcare providers to reach patients in remote areas and improve overall healthcare accessibility. The prevalence of chronic diseases in the MEA region has led to a focus on therapeutic devices for chronic disease management. Devices for diabetes management, cardiovascular care, and respiratory conditions are among those experiencing increased demand. Point-of-care testing devices, which enable rapid diagnostic tests and immediate results, are gaining popularity. These devices are particularly useful in resource-constrained settings and help in early detection and treatment initiation. The integration of digital health technologies and mobile health applications is influencing the therapeutic device market. Mobile apps connected to therapeutic devices provide real-time data, facilitate patient engagement, and support better adherence to treatment plans. Wearable devices for health monitoring and fitness tracking have gained popularity. These devices can track vital signs, monitor physical activity, and provide valuable data for both patients and healthcare providers. The Internet of Things (IoT) is being increasingly utilized in healthcare settings. Therapeutic devices connected to IoT networks enable data sharing, remote monitoring, and the development of smart healthcare ecosystems. Medical tourism, where individuals travel to the MEA region for medical treatment, is influencing the demand for advanced therapeutic devices. International collaboration and partnerships with healthcare providers from other regions contribute to the exchange of medical technologies. Sustainability is becoming a consideration in healthcare practices. Therapeutic devices that are environmentally friendly, energy-efficient, and produced using sustainable materials are gaining interest.

In terms of country the market is segmented into United Arab Emirates, Saudi Arabia and South Africa. The United Arab Emirates has experienced significant economic growth and development, particularly in cities like Dubai and Abu Dhabi. The robust economic conditions often correlate with increased healthcare spending and demand for advanced medical technologies. The United Arab Emirates government has been actively investing in the healthcare sector, aiming to enhance healthcare infrastructure and services. Increased funding for healthcare often translates into higher adoption rates for therapeutic devices. The United Arab Emirates, particularly Dubai, has positioned itself as a hub for medical tourism. The availability of advanced medical facilities and a focus on attracting international patients can contribute to a higher demand for cutting-edge therapeutic devices. As with many developed nations, the United Arab Emirates is witnessing an increase in lifestyle-related diseases, such as cardiovascular diseases and diabetes. Furthermore, The United Arab Emirates has experienced significant economic growth and development, particularly in cities like Dubai and Abu Dhabi. The robust economic conditions often correlate with increased healthcare spending and demand for advanced medical technologies. In addition, South Africa faces challenges related to infectious diseases such as HIV/AIDS and tuberculosis. The on-going efforts to manage and treat these diseases contribute to the demand for diagnostic and therapeutic devices. Furthermore, Efforts to strengthen primary healthcare services in South Africa drive the demand for point-of-care and primary care therapeutic devices.

According to the report based on product market is bifurcated into Insulin Delivery Devices, Dialysis Equipments, Ventilators, IV Equipments, Sleep Apnea Therapeutic Device, Wound Care Management, Respiratory Care and Others. Among them, Insulin Delivery Devices segment is leading the market. Among them, the Wound Care Management segment is leading the market. The Middle East & Africa region is witnessing demographic shifts, including an aging population. Elderly individuals are more susceptible to chronic wounds due to factors such as reduced skin elasticity and compromised immune function. The aging demographic contributes to an increased demand for wound care management devices. Diabetes and obesity are significant risk factors for chronic wounds. The increasing prevalence of diabetes and obesity in the Middle East & Africa region contributes to a higher incidence of conditions like diabetic foot ulcers, emphasizing the need for effective wound care management. Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are prevalent in the Middle East & Africa region. Factors such as diabetes, vascular diseases, and poor wound healing contribute to the higher incidence of chronic wounds, driving the demand for advanced wound care management solutions. Advances in wound care technologies, including the development of sophisticated dressings, negative pressure wound therapy (NPWT) devices, and bioactive wound care products, have contributed to the growth of the wound care management segment. These technologies offer improved healing outcomes and drive market demand. Innovations in biomaterials and biologics for wound care have opened new avenues for therapeutic interventions. Advanced wound dressings and bioactive products contribute to improved healing outcomes and are driving the demand for these innovative solutions.

Based on end user market is bifurcated into Hospitals and Clinics, Home care Settings, Ambulatory Care Centers (ACCs) and Other End User. Hospitals and clinics are central components of the healthcare delivery system in the MEA region. These facilities serve as primary points for patient care, diagnosis, treatment, and rehabilitation, contributing to a high volume of therapeutic device usage. Hospitals and clinics offer a wide range of specialized medical services, including surgery, intensive care, and specialty clinics. The diverse medical services provided in these settings necessitate the use of a variety of therapeutic devices, from surgical instruments to patient monitoring devices. Hospitals and clinics in the MEA region are equipped with advanced diagnostic and treatment facilities. This includes imaging devices, surgical equipment, and other therapeutic devices that are essential for providing comprehensive healthcare services to patients. Hospitals accommodate both inpatient and outpatient care, covering a broad spectrum of healthcare needs. The demand for therapeutic devices is high in both settings, as inpatients require devices for continuous monitoring and treatment, while outpatients may need devices for diagnostics and follow-up care. Hospitals are equipped to provide emergency and critical care services, requiring a wide array of therapeutic devices such as life support systems, defibrillators, and other emergency medical equipment. The critical nature of these services contributes to the demand for advanced therapeutic devices. Teaching hospitals and research institutions are integral to medical education and research in the MEA region. These institutions often have state-of-the-art facilities and are early adopters of innovative therapeutic devices, contributing to market growth.

In terms of indication, the market is split into wound care, diabetes, respiratory diseases, cardiovascular disorders and hypertension, cancer, pregnancy, hearing disorders, movement disorders, and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Movement disorders, including Parkinson's disease, essential tremor, and dystonia, are prevalent in the MEA region. The ageing population, changing lifestyles, and other factors contribute to the increasing incidence of movement disorders, driving the demand for therapeutic devices in this segment. Growing awareness about movement disorders and advancements in diagnostic technologies contribute to early and accurate diagnosis. As more individuals are diagnosed with movement disorders, there is an increased demand for therapeutic devices that can effectively manage and alleviate symptoms. Neurostimulation devices, such as DBS implants, have shown promising results in improving patient outcomes, including symptom control and quality of life. Positive outcomes contribute to the acceptance and adoption of neurostimulation therapies for movement disorders. Some patients prefer non-pharmacological interventions for the management of movement disorders. Neurostimulation devices provide an alternative to traditional drug-based therapies, offering a more targeted and personalised approach to treatment.

Companies Covered in this report:

Novo Nordisk A/S , Sanofi S.A., Medtronic plc , Terumo Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG,, B. Braun Melsungen AG, Baxter International Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, WS Audiology A/S, Koninklijke Philips N.V.

Considered in this report

• Geography: Middle East & Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Middle East & Africa Therapeutic Device market Outlook with its value and forecast along with its segments
• Country-wise Therapeutic Device market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United Arab Emirates
• Saudi Arabia
• South Africa

By Product

• Insulin Delivery Devices
• Dialysis Equipments
• Ventilators
• IV Equipments
• Sleep Apnea Therapeutic Device
• Wound Care Management
• Respiratory Care
• Others

By End User

• Hospitals and Clinics
• Home care Settings
• Ambulatory Care Centers (ACCs)
• Other End User

By Indication

• Wound Care
• Diabetes
• Respiratory Diseases
• Cardiovascular Disorders & Hypertension
• Cancer
• Pregnancy
• Hearing Disorders
• Movement Disorders
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Therapeutic Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents